The showdown over financing for developing countries comes in a...
Category:
Risk Management
Latest
Adani’s bribery scandal raises concern on market, public disclosure lapses
"The Adani Group can argue about the materiality of the...
FPI selling spree continues in Nov at Rs 26 533 cr, intensity of outflow reduces
The relentless selling by FIIs continued in November. After selling...
Clarity Over Coverage is Critical as COVID-19 Casts a Shadow over Jan Renewals
The biggest challenge at this renewal, however, is undoubtedly exclusionary language and clarity of wordings related to COVID-19 – particularly loss occurrence clauses and, where relevant, claim payments or claims validity.
Munich Re and Porsche form JV, to offer innovative manufacturing, software and financial mangement expertise
Torsten Jeworrek, member of Munich Re’s Board of Managementsaid,“With the FlexFactory, we and our partners have created a future-oriented platform for opening up new markets, which addresses a central challenge of modern production. Our cooperation once again underlines Munich Re’s innovative power and solution competence as a risk manager and financing expert for Industry 4.0.”
Annual global modeled insured average Cat losses in 2020 at $100 billion:AIR Worldwide
“The ability for the global (re)insurance industry, financial institutions, governments, and non-governmental organizations to prepare for large losses before they occur is critical to continued solvency and resilience,” said Rob Newbold, executive vice president at AIR Worldwide.
Insurers cannot provide unlimited cover in pandemic, UK Supreme Court told
The case revolves around whether 21 policy wordings, affecting potentially 700 types of policies, 60 insurers, 370,000 policyholders and billions of pounds in claims, should cover disruption caused by the virus.
The wordings cover business interruption when insured premises cannot be accessed because of public authority restrictions, in the event of a notifiable disease within a specified radius and hybrid wordings.
Indian drug firms recall various products in US market
As per the USFDA, the company is recalling the product due to deviation from the current good manufacturing practices (CGMP).
“FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,” it noted.
Northern India chokes on toxic smog day after Diwali festival
Revellers in the capital let off huge amounts of fireworks well into Sunday morning, prompting angry residents and environmentalists to complain on social media of breathing difficulties and stinging eyes.
Yield mania gives much needed break to indebted emerging-market countries
US elections have revived the yield hunt, granting much-needed breathing space to governments in developing economies. They face the equivalent of about $3 trillion in local debt maturing next year after a borrowing binge in short-term bonds that were mostly bought by local banks in the absence of international investors.
Should Millennials and Gen Z Get the Vaccine First?
But what if vaccinating the elderly first isn’t the best way to minimize fatalities? A recently published (but not yet peer-reviewed) model from three academics at Khalifa University suggests priority should be accorded to groups with the highest number of daily in-person interactions, since that amplifies the vaccine’s effectiveness by reducing infections (and mortality) both among the vaccinated group and those they come into contact with.
According to their model, proper prioritization can reduce total fatalities by up to 70%.
China regulator says financial innovation must not create oligopolies
Xiao Yuanqi, chief risk officer at the China Banking and Insurance Regulatory Commission (CBRIC) told the Caixin Summit in Beijing that innovation should not undermine healthy competition or let innovation pioneers become hindrances to further innovation.
Microsoft urges action on health care cyber attacks
“In recent months, we’ve detected cyberattacks from three nation-state actors targeting seven prominent companies directly involved in researching vaccines and treatments for Covid-19,” said Microsoft’s vice-president for security issues Tom Burt.